Cholesterol is an organic molecule, which is found in all the cells of body. Cholesterol is the precursor to vitamin D and certain hormones. Increase in cholesterol levels in the blood could lead to formation of plaque (atherosclerosis). High cholesterol has no symptoms. A blood test is the only way to detect high cholesterol. Cholesterol testing aids in measuring cholesterol and triglyceride levels in the blood and it is called as lipoprotein profiling or lipoprotein analysis. Blood cholesterol testing aids to reduce the risk of stroke, heart attack, and peripheral artery diseases.
Obese and geriatric population is susceptible to high levels of cholesterol, this is expected to aid in growth of the cholesterol testing services market. The concentration of cholesterol in plasma increase with age. According to a study published in NCBI in 2013, the cholesterol level increases in men from puberty to 45-55 years, and then decreases. Moreover, among women this time period of increase in cholesterol level expends a decade (i.e. until 55 – 65 years), and then starts decreasing. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) 2016, Asia Pacific region constitutes about 60% of the world’s geriatric population. It is estimated that in 2016, around 547 million people were aged above 60 years in Asia Pacific region, and this number is expected to double and reach around 1.3 billion by 2050. According to a study published in Centers for Disease Control and Prevention in 2014, the prevalence of obesity was estimated to be 36.5% among adults in the U.S. Prevalence of obesity among middle-aged adults aged 40–59 (40.2%) years and older adults aged 60 and above years (37.0%) was higher than among younger adults aged 20–39 (32.3%), prevalence of obesity among women (38.3%) was higher than among men (34.3%) in U.S. Furthermore, increasing awareness regarding healthcare and regular checkups among population in both developed and emerging economies is expected to drive growth of the global cholesterol testing services market.
Click To Continue Reading On Cholesterol Testing Services Market
According to a study published by Center for Disease Control and Prevention in 2012, about 95 million adults in the U.S. aged 20 years or older have total cholesterol levels greater than 200 mg/dL, and nearly 29 million adults have total cholesterol levels higher than 240 mg/dL in the U.S. As per medical standard, total cholesterol level below 200 mg/dl is good, and between 200-239 mg/dl is called as borderline. Increasing prevalence of high cholesterol among the populace is expected to increase demand for its diagnosis and testing, which conversely is expected to create a conducive environment for growth of global cholesterol testing services market.
The global cholesterol testing services market was valued at US$ 11.5 Bn in 2016 and is expected to witness a CAGR of 7.8% over the forecast period (2017–2025).
Download The PDF Brochure:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154